Apollo launches Genomics Institute in Chennai
Apollo continues to invest in genomics technology and research for better patient care
Apollo continues to invest in genomics technology and research for better patient care
The New State-of-Art OligoPilot 2000 solid-phase synthesizer adds cGMP manufacturing capacity to support and accelerate clinical and commercial oligonucleotide programs.
The USFDA had classified the inspection as "Official Action Indicated" (OAI).
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
The interaction with key Government Officials and industry leaders led to a joint exploration of possible collaboration and investments in the Healthcare ecosystem between the two countries
Fully equipped labs with 75-member team set-up and made operational in <100 days
The acquisition would be by way of a share purchase agreement dated Dec. 26, 2022.
SÜDPACK is setting standards in terms of both performance and sustainability
Gafchromic films support patient care in oncology
Showcased digital innovations: MyPKFit, SYNAPSE and Athena at the G20 Health Working Group Meeting
Subscribe To Our Newsletter & Stay Updated